Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for WORXD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -0.0057M
March 31, 2026 -0.2527M
December 31, 2025 -0.1291M
September 30, 2025 -0.3581M
June 30, 2025 -0.6518M
March 31, 2025 -0.4046M
December 31, 2024 -0.1344M
September 30, 2024 -0.3626M
June 30, 2024 -0.5278M
March 31, 2024 -0.0595M
December 31, 2023 -0.1049M
September 30, 2023 -0.3728M
June 30, 2023 -0.3478M
March 31, 2023 0.0193M
December 31, 2022 -0.1123M
September 30, 2022 -0.3868M
June 30, 2022 0.0152M
March 31, 2022 -0.0628M
December 31, 2021 -0.3305M
September 30, 2021 -0.2555M
June 30, 2021 -0.057M
March 31, 2021 -0.4269M
Date Value
December 31, 2020 0.1853M
September 30, 2020 -0.1434M
June 30, 2020 -0.7141M
March 31, 2020 -0.2869M
December 31, 2019 -0.4438M
September 30, 2019 -0.3057M
June 30, 2019 -1.376M
March 31, 2019 -2.566M
December 31, 2018 -0.6477M
September 30, 2018 -0.2286M
June 30, 2018 0.6296M
March 31, 2018 0.0056M
December 31, 2017 -1.248M
September 30, 2017 -1.445M
June 30, 2017 -1.880M
March 31, 2017 -1.257M
December 31, 2016 -1.154M
September 30, 2016 -0.6188M
June 30, 2016 -0.1232M
March 31, 2016 -0.1222M
December 31, 2015 -0.1575M
September 30, 2015 -0.0747M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. -0.055M
Health Catalyst, Inc. 0.275M
GoodRx Holdings, Inc. 80.83M
Claritev Corp. 92.67M
iSpecimen, Inc. -0.6896M